Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation
In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.
Primary Sponsor
Collaborating Groups
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
Participating Centres
Accrual Target
472
Current Accrual
Trial Chairperson
Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia
Dr Mark Sidhom, Liverpool Hospital, NSW, Australia
Trial Contact
ninjatrial@calvarymater.org.au
Clinical Trial Registration
Related Post
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
